Related Experiment Video
Updated: Jun 12, 2025

Characterization at the Molecular Level using Robust Biochemical Approaches of a New Kinase Protein
Published on: June 30, 2019
LIMK1 variants are associated with divergent endocrinological phenotypes and altered exocytosis dynamics
Irena J J Muffels1, Theodore Carter2, Holger Rehmann3
1Department of Metabolic Diseases, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, the Netherlands.
Insights
De novo variants in LIM kinase 1 (LIMK1) cause distinct actin remodeling and exocytosis defects, impacting development and glucose regulation. This study reveals LIMK1
Area of Science:
- Molecular biology
- Genetics
- Endocrinology
Background:
- LIM kinase 1 (LIMK1) is crucial for actin remodeling and exocytosis via cofilin phosphorylation.
- LIMK1 de novo variants can lead to diverse clinical presentations.
Purpose of the Study:
- To investigate the functional impact of two distinct LIMK1 de novo variants.
- To correlate these variants with observed phenotypic differences in patients.
Main Methods:
- Analysis of patient phenotypes: epileptic encephalopathy, developmental delay, immune deficiency, and glucose dysregulation.
- Assessment of actin polymerization levels in affected individuals.
- Functional studies of insulin-secreting cell lines expressing LIMK1 variants to evaluate exocytosis dynamics and insulin secretion.
Main Results:
- Individual 1 with a LIMK1 variant showed decreased actin polymerization and slower exocytosis, associated with neurological and developmental issues.
- Individual 2 with a different LIMK1 variant exhibited increased actin polymerization and rapid, uncontrolled exocytosis, linked to immune and metabolic dysfunction.
- Both variants resulted in increased overall insulin secretion despite differing exocytosis rates.
Conclusions:
- LIMK1 variants can have opposing effects on cofilin phosphorylation and actin dynamics, leading to divergent phenotypes.
- Dysregulated insulin exocytosis due to LIMK1 variants may contribute to glucose dysregulation.
- This study highlights LIMK1's critical role in fine-tuning insulin secretion and its broader physiological implications.
Abstract:
LIM kinase 1 (LIMK1) plays a pivotal role in dynamic actin remodeling through phosphorylation of cofilin, thereby regulating exocytosis. We report two individuals harboring LIMK1 de novo variants with dissimilar phenotypes: one exhibited epileptic encephalopathy and developmental delay, while the other showed common variable immune deficiency and glucose dysregulation. We suspected that the divergent phenotypic features arose from opposing effects on LIMK1 activity. Indeed, actin polymerization was significantly decreased in individual 1, whereas it was increased in individual 2. Insulin-secreting cell lines expressing the LIMK1 variant of individual 1 exhibited significantly slower exocytosis, contrasting the rapid and uncontrolled exocytosis in individual 2. Intriguingly, both variants led to increased overall insulin secretion. This first report of two individuals with LIMK1 variants with divergent effects on cofilin phosphorylation and actin polymerization, reveals that LIMK1 has an important role in tuned insulin exocytosis. These distinct exocytosis defects may underlie the glucose dysregulation observed.
Related Concept Videos
Lysosomal Hydrolases
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
The Early Endosome: Endocytosis of Transferrin
Smooth Endoplasmic Reticulum
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
Pleiotropy
Intralumenal Vesicles and Multivesicular Bodies

